The Technical Analyst
Atomo Diagnostics Ltd [AT1.AX]
Exchange: ASX Industry: Health Care Equipment & Services
Atomo Diagnostics Ltd Price, Forecast, Insider, Ratings, Fundamentals & Signals
3.33% $0.0310
America/New_York / 3 mai 2024 @ 01:01
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 19.82 mill |
| EPS: | -0.0100 |
| P/E: | -3.10 |
| Earnings Date: | Feb 25, 2024 |
| SharesOutstanding: | 639.20 mill |
| Avg Daily Volume: | 1.499 mill |
| RATING 2024-05-03 |
|---|
| C |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Sell | |
| P/E: | Sell | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/21 | 4/21 | 2/22 | 4/22 | 2/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -3.10 | sector: PE 1.258 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.06x |
| Company: PE -3.10 | industry: PE 54.21 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0280 - 0.0320 ( +/- 6.67%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
Forecast
1: 15:11 - $0.0300
Forecast 2: 16:00 - $0.0310
Forecast 3: 16:00 - $0.0310
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.0310 (3.33% ) |
| Volume | 0.159 mill |
| Avg. Vol. | 1.499 mill |
| % of Avg. Vol | 10.62 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For AT1.AX
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
AT1.AX
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. It offers rapid diagnostic test devices for COVID-19, HIV screening, pregnancy test, and respiratory test. The company was incorporated in 2010 and is headquartered in Leichhardt, Australia.